FDA May Step In After High Court Shields Generic-Drug Cos.
All eyes are on the U.S. Food and Drug Administration after the U.S. Supreme Court on Monday blocked design defect lawsuits against generic-drug makers, according to experts who predict that regulators...To view the full article, register now.
Already a subscriber? Click here to view full article